Free Trial

Synergy Asset Management LLC Sells 91,973 Shares of Procter & Gamble Company (The) $PG

Procter & Gamble logo with Consumer Staples background

Key Points

  • Synergy Asset Management LLC has reduced its stake in Procter & Gamble by 96.4%, selling 91,973 shares and leaving it with only 3,467 shares valued at $552,000.
  • In contrast, Kingstone Capital Partners Texas LLC increased its investment by an impressive 655,209.0%, acquiring over 76 million shares and making it the largest shareholder.
  • Recent analyst reports have downgraded Procter & Gamble's price targets, with BNP Paribas Exane lowering its target from $177 to $172 while maintaining an "outperform" rating.
  • Five stocks to consider instead of Procter & Gamble.

Synergy Asset Management LLC lessened its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 96.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,467 shares of the company's stock after selling 91,973 shares during the quarter. Synergy Asset Management LLC's holdings in Procter & Gamble were worth $552,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in PG. Kingstone Capital Partners Texas LLC lifted its stake in Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares in the last quarter. Northern Trust Corp grew its position in shares of Procter & Gamble by 0.8% during the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company's stock valued at $5,051,930,000 after purchasing an additional 248,792 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Procter & Gamble by 3.5% in the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company's stock worth $2,966,252,000 after buying an additional 583,629 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company's stock valued at $2,947,146,000 after buying an additional 1,018,865 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.

Insider Activity

In other Procter & Gamble news, insider Susan Street Whaley sold 1,000 shares of the company's stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $156.84, for a total value of $156,840.00. Following the transaction, the insider directly owned 28,436 shares in the company, valued at $4,459,902.24. This represents a 3.40% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jennifer L. Davis sold 8,596 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,351,892.92. Following the completion of the sale, the chief executive officer owned 64,991 shares of the company's stock, valued at $10,221,134.57. The trade was a 11.68% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 120,181 shares of company stock valued at $18,918,012. Insiders own 0.20% of the company's stock.

Analysts Set New Price Targets

PG has been the topic of several recent research reports. BNP Paribas Exane decreased their price objective on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating on the stock in a report on Tuesday, September 23rd. Wells Fargo & Company decreased their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating on the stock in a research note on Thursday, September 25th. Barclays dropped their price objective on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating for the company in a research note on Wednesday. Evercore ISI restated an "in-line" rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Finally, JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble currently has an average rating of "Moderate Buy" and an average price target of $173.11.

Check Out Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Stock Performance

Shares of NYSE:PG opened at $152.19 on Friday. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The company has a market capitalization of $356.20 billion, a price-to-earnings ratio of 23.38, a PEG ratio of 4.01 and a beta of 0.36. Procter & Gamble Company has a 12 month low of $149.91 and a 12 month high of $180.43. The firm's 50-day moving average is $155.51 and its 200 day moving average is $160.06.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. During the same quarter in the previous year, the business earned $1.40 earnings per share. The company's revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts predict that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were given a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. The ex-dividend date was Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is 64.98%.

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read More

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Travel Stocks to Buy Before the Holidays
5 Hot Stocks to Buy Now: October’s Top Picks With Major Upside
5 Secret Tech Stocks Wall Street Missed

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines